Introduction
Ganciclovir 1 ( Figure 1 ) is a guanine containing acyclic nucleoside drug (Cytovene, RxList) used to treat infections caused by herpes family viruses and cytomegalovirus. 1, 2 In view of its substantial commercial importance, several synthetic routes were developed for ganciclovir using guanine, 3, 4 acetylguanine, 3 2-amino-6-chloropurine, 3 ,5 tetraacetylguanosine, 6, 7 and diacetylguanine 2 (Figure 1 ), [8] [9] [10] [11] as the source of guanine moiety. Coupling of one of such guanine derivatives with an appropriately protected, activated glycerol derivative such as 1,3-diacetoxy-2-acetoxymethoxy propane or 1,3-dibenzyloxy-2-acetoxymethoxy propane is the commonly employed strategy to access ganciclovir. 
Results and Discussion
In our current approach, a new, readily accessible masked glycerol derivative, 2-acetoxymethoxy-1,1-diethoxy-3-trityloxypropane 4 is used as a source of 1,3-dihydroxy-2-propoxymethyl moiety in the synthesis of ganciclovir (Scheme 1). Acetal and trityloxy functions of 4 can be readily transformed into the desired hydroxyls under mild conditions in the final stage of synthetic sequence. In the reported processes for the introduction of acetoxymethyl moiety onto the secondary hydroxyl function of appropriate terminal protected glycerol derivatives, a two step protocol involving chloromethylation and subsequent nucleophilic displacement with acetoxy was practiced. 8, 12 We have developed a relatively simple and convenient one step process for functionalizing the secondary hydroxyl to furnish the desired intermediate 4.
Selective tritylation of the commercially available glyceraldehyde diethyl acetal gave 1,1-diethoxy-3-trityloxypropan-2-ol (3). 13 Reaction of 3 with chloromethyl acetate in the presence of sodium hydride in DMF provided the desired substrate 4 in good yields. Among several reagent/ solvent combinations (Table 1) , NaH/ DMF was proved to be an apt combination to facilitate the conversion of 2-propanol derivative 3 into the desired intermediate 4 (Entry 6, Table 1 ). The mode of addition of reagents had a tremendous effect on the yield of the reaction. The reaction proceeded with formation of impurities upon successive addition of NaH, 3 and chloromethyl acetate in DMF thereby resulting in low yield of 4, the major impurity being the acetyl derivative of 3. The yield drastically increased by first activation of 3 using NaH followed by dropwise addition of this activated 3 to chloromethyl acetate in DMF. Such a one step chloromethylation of secondary hydroxyl function to get similar structural motif was hither to be unknown in the literature.
Reaction of 4 with diacetylguanine 2 was conducted in dimethylacetamide in the presence of methanesulfonic acid to give 5 (44%). The acetamido guanine derivative 5 could be smoothly transformed into its corresponding amino derivative 6 (79%) on alkaline hydrolysis in methanol. The preparation of 5 and 6 were done by following the similar procedure reported in literature. 10 Concomitant deprotection of acetal and trityl functions of 6 using TFA in DCM and subsequent reduction of the aldehyde derivative using NaBH 4 in the same pot directly furnished ganciclovir 1 (73%). The formation of 1 (16% when calculated from 3) was confirmed by comparison of analytical data with that of authentic compound reported in literature. 8 
Conclusions
In conclusion, readily accessible substrates, relatively mild reaction conditions and simple inexpensive deprotection operations render our approach to ganciclovir attractive. Further application of this synthetic protocol in the synthesis of structurally similar and commercially important antiviral active pharmaceutical ingredients is under exploration.
Experimental Section
General. IR spectra were recorded in the solid state as a KBr dispersion using a Perkin-Elmer FT-IR spectrophotometer.
1 H NMR spectra were scanned in DMSO-d 6 on a Mercury Plus spectrometer with TMS as an internal standard. HR-MS spectra were obtained on Waters LCT Premier XE (Micro mass Oa-TOF) instrument. The solvents and reagents were used without any purification.
Preparation of 2-acetoxymethoxy-1,1-diethoxy-3-trityloxypropane (4).
To a solution of NaH (144 mg, 6 mmol) in anhydrous DMF (25 mL) was added 1,1-diethoxy-3-trityloxypropan-2-ol 3 13 (4.06 g, 10 mmol) at room temperature and reaction mixture was stirred for 10 h under N 2 .
This solution was added dropwise at regular intervals to a cooled solution of chloromethyl acetate (1.0 mL, 10 mmol) in DMF (25 mL) at 15-20 ºC. The reaction mixture was stirred for 5-6 h, quenched with chilled water and extracted with diisopropyl ether. 
-acetyl-9-[(1,1-diethoxy-3-trityloxy-2-propoxy)methyl]guanine (5).
To a solution of diacetylguanine 2 (1.41 g, 6 mmol) and 2-acetoxymethoxy-1,1-diethoxy-3-trityloxypropane 4 (2.9 g, 6 mmol) in dimethylacetamide (30 mL) was added methanesulfonic acid (0.1 mL, 1.2 mmol) at room temperature. The reaction mixture was heated at 75-80 ºC for 20-21 h, cooled to room temperature and extracted with DCM. The DCM layer was dried over sodium sulfate and concentrated under vacuum to give crude compound 5, which was purified by column chromatography eluting with 4% MeOH in CHCl 3 ; yield: 
Preparation of ganciclovir (1).
A mixture of compound 6 (569 mg, 1 mmol) and TFA (0.3 mL, 4 mmol) in DCM (10 mL) was stirred at room temperature for 4h. The solvent was stripped off under reduced pressure and MeOH (20 mL) was added to the residue and the solution was stirred at 10-15 ºC. Sodium borohydride (45.6 mg, 1.2 mmol) was added in portions and the mixture was stirred for 2 h at 25 ºC. The reaction mixture was poured into cold water, the solid obtained was filtered and recrystallized from MeOH to give ganciclovir as a white solid 
